Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.
Related healthcare insights
Article
Small and emerging biopharma companies are already having an impact on the industry. Learn how RWD can enhance the ability to innovate.
Article
Cut through the noise of the Inflation Reduction Act of 2022 with key points aimed to help life sciences leaders leverage impactful data.
Article
Discover how using real-world evidence (RWE) in the life sciences industry can help catapult learning and drive impact for your company.